A. Brogi

Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia

V. Santini, A. Sanna, A. Gozzini, 2017, Haematologica.

Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures

A. Arcangeli, S. Pillozzi, V. Santini, 2018, Oncotarget.

A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study

G. Castellani, F. Solé, T. Haferlach, 2022, The Lancet. Haematology.

PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes

A. Iolascon, I. Andolfo, V. Santini, 2023, American journal of hematology.